| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |